Alfuzosin Hydrochloride, extended release 10 mg / 1 Tablet 90 Tablet

Reference details for licensed healthcare facility review and verification.

Alfuzosin Hydrochloride, extended release NDC Family 69097-0844 Alfuzosin Hydrochloride, extended release 10 mg / 1

NDC 11	69097-0844-05
Product NDC	69097-0844
Generic Drug Name	Alfuzosin Hydrochloride, extended release
Brand Name	Alfuzosin Hydrochloride, extended release
Manufacturer	Cipla USA Inc.
Strength	10 mg / 1
Dosage Form	Tablet
Drug Type	Oral
Package Quantity	90 Tablet
Package Description	90 TABLET in 1 BOTTLE (69097-844-05)
Active Ingredients	Alfuzosin Hydrochloride
Marketing Category	ANDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this package-level listing or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Alfuzosin Hydrochloride, extended release 10 mg / 1 Tablet is tracked under NDC 69097-0844-05 and rolls up into product family 69097-0844. Use this page to review package-level identifiers before comparing related family pages or starting a quote review.

Package configuration: 90 Tablet.
Manufacturer: Cipla USA Inc..
Dosage form: Tablet.
Family size: 4 indexed presentations.

Click a tag to refine the catalog view around this product reference.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Alternate presentations in this family

These nearby package-level pages can help healthcare teams compare related packaging or presentation differences inside the same product-NDC family.

Alfuzosin Hydrochloride, extended release 10 mg / 1 Tablet 100 TabletNDC 69097-0844-07 | 100 Tablet | Cipla USA Inc.Alfuzosin Hydrochloride, extended release 10 mg / 1 Tablet 30 TabletNDC 69097-0844-02 | 30 Tablet | Cipla USA Inc.

Alfuzosin Hydrochloride, extended release 10 mg / 1 Tablet 90 Tablet, NDC 69097-0844-05, is a Cipla USA Inc. 10 mg / 1 tablet presentation packaged as 90 Tablet.

NDC search formats

Canonical NDC 11: 69097-0844-05
Digits-only NDC 11: 69097084405
Possible 10-digit display formats: 69097-844-05 (6909784405), 69097-0844-5 (6909708445)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links